Jing Liu

affiliation not provided to SSRN

No Address Available

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

36

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Repurposing of Clinical-Stage Flt3 Inhibitor Hyml-122 as a Potent Ripk2 Inhibitor for the Treatment of Inflammatory Bowel Disease

Number of pages: 50 Posted: 13 Feb 2025
Jie Hu, Juan Liu, Fengming Zou, Xixiang Li, Hongwei Yu, Beilei Wang, Li Wang, Jun Tang, Xilu Hou, Qian Gao, Jiaoxue Wang, Xing He, Yanjie Chen, Hezhong Yan, Jing Liu, Aoli Wang, Wenchao Wang and Qingsong Liu
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 36 (969,943)

Abstract:

Loading...

HYML-122, RIPK2, inhibitors, inflammatory diseases, inflammatory bowel disease